Terug
37
Dagbereik
€ 102,41
€ 104,25
52-Weeksbereik
€ 102,41
€ 139,06
Volume
11.747.104
50D / 200D Gem.
€ 113,11
/
€ 125,68
Vorige Slotkoers
€ 104,85
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 27,7 | 0,3 |
| P/B | 3,5 | 2,9 |
| ROE % | 13,1 | 3,7 |
| Net Margin % | 14,7 | 3,8 |
| Rev Growth 5Y % | 0,7 | 10,0 |
| D/E | 0,3 | 0,2 |
Koersdoel Analisten
Hold
€ 137,67
+32.3%
Low: € 120,00
High: € 158,00
Forward K/W
18,5
Forward WPA
€ 5,68
WPA Groei (sch.)
+0,0%
Omzet Sch.
48 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 8,36
€ 8,22 – € 8,71
|
63 B | 4 |
| FY2029 |
€ 7,56
€ 7,43 – € 7,88
|
59 B | 4 |
| FY2028 |
€ 6,87
€ 5,93 – € 7,45
|
55 B | 11 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 |
Shroff Eric
Senior Vice President
|
sell | 709 | € 115,58 | € 81.946 |
| Mar 2, 2026 |
Cushman Elizabeth C.
EVP, GC AND SECRETARY
|
sell | 263 | € 115,58 | € 30.398 |
| Mar 2, 2026 |
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
|
sell | 1.144 | € 115,58 | € 132.224 |
| Feb 27, 2026 |
Shroff Eric
Senior Vice President
|
other | 1.384 | € 116,26 | € 160.904 |
| Feb 27, 2026 |
Boudreau Philip P
EVP AND CFO
|
other | 7.441 | € 116,26 | € 865.091 |
| Feb 27, 2026 |
Ford Robert B
CHAIRMAN AND CEO
|
other | 30.308 | € 116,26 | € 3.523.608 |
| Feb 27, 2026 |
Cushman Elizabeth C.
EVP, GC AND SECRETARY
|
other | 1.421 | € 116,26 | € 165.205 |
| Feb 27, 2026 |
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
|
other | 4.040 | € 116,26 | € 469.690 |
| Feb 24, 2026 |
Ford Robert B
CHAIRMAN AND CEO
|
grant | 427.530 | — | — |
| Dec 31, 2025 |
Stratton John G
|
grant | 313 | € 125,29 | € 39.216 |
| Dec 31, 2025 |
Roman Michael F
|
grant | 301 | € 125,29 | € 37.712 |
| Dec 11, 2025 |
Salvadori Daniel Gesua Sive
EVP AND GROUP PRESIDENT
|
other | 1.536 | € 123,28 | € 189.358 |
| Sep 30, 2025 |
Stratton John G
|
grant | 293 | € 133,94 | € 39.244 |
| Jun 30, 2025 |
Stratton John G
|
grant | 282 | € 136,01 | € 38.355 |
| Jun 30, 2025 |
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
|
other | 269 | € 134,38 | € 36.148 |
| Jun 30, 2025 |
Gonzalez Patricia Paola
|
grant | 242 | € 136,01 | € 32.914 |
| Apr 30, 2025 |
Blount Sally E.
|
sell | 2.600 | € 129,66 | € 337.116 |
| Apr 25, 2025 |
Roman Michael F
|
grant | 1.635 | — | — |
| Apr 25, 2025 |
McDew Darren W
|
grant | 1.635 | — | — |
| Mar 31, 2025 |
Gonzalez Patricia Paola
|
grant | 248 | € 132,65 | € 32.897 |
Belangrijkste Punten
Revenue grew 0,72% annually over 5 years — modest growth
Earnings declined -51,32% over the past year
ROE of 13,07% — decent returns on equity
Debt/Equity of 0,29 — conservative balance sheet
Generating 7,40B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,95%
Groei
Revenue Growth (5Y)
0,72%
Revenue (1Y)5,67%
Earnings (1Y)-51,32%
FCF Growth (3Y)20,90%
Kwaliteit
Return on Equity
13,07%
ROIC8,98%
Net Margin14,72%
Op. Margin18,16%
Veiligheid
Debt / Equity
0,29
Current Ratio1,58
Interest Coverage23,60
Waardering
P/E Ratio
27,72
P/B Ratio3,47
EV/EBITDA23,28
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,67% | Revenue Growth (3Y) | 5,13% |
| Earnings Growth (1Y) | -51,32% | Earnings Growth (3Y) | 6,77% |
| Revenue Growth (5Y) | 0,72% | Earnings Growth (5Y) | -1,99% |
| Profitability | |||
| Revenue (TTM) | 44,33B | Net Income (TTM) | 6,52B |
| ROE | 13,07% | ROA | 7,52% |
| Gross Margin | 55,51% | Operating Margin | 18,16% |
| Net Margin | 14,72% | Free Cash Flow (TTM) | 7,40B |
| ROIC | 8,98% | FCF Growth (3Y) | 20,90% |
| Safety | |||
| Debt / Equity | 0,29 | Current Ratio | 1,58 |
| Interest Coverage | 23,60 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 27,72 | P/B Ratio | 3,47 |
| P/S Ratio | 4,08 | PEG Ratio | -0,65 |
| EV/EBITDA | 23,28 | Dividend Yield | 0,02% |
| Market Cap | 180,82B | Enterprise Value | 187,37B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 44,33B | 41,95B | 40,11B | 43,65B | 43,08B |
| Net Income | 6,52B | 13,40B | 5,72B | 6,93B | 7,07B |
| EPS (Diluted) | 3,72 | 7,64 | 3,27 | 3,91 | 3,94 |
| Gross Profit | 24,61B | 21,33B | 20,04B | 22,32B | 23,21B |
| Operating Income | 8,05B | 6,83B | 6,44B | 8,36B | 9,20B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 86,71B | 81,41B | 73,21B | 74,44B | 75,20B |
| Total Liabilities | 33,94B | 33,51B | 34,39B | 37,53B | 39,17B |
| Shareholders' Equity | 52,13B | 47,66B | 38,60B | 36,69B | 35,80B |
| Total Debt | 15,07B | 15,28B | 15,87B | 17,95B | 19,25B |
| Cash & Equivalents | 8,52B | 7,62B | 6,90B | 9,88B | 9,80B |
| Current Assets | 26,00B | 23,66B | 22,67B | 25,22B | 24,24B |
| Current Liabilities | 16,50B | 14,16B | 13,84B | 15,49B | 13,11B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#697 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026